Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
9.56 SEK | -0.21% | +0.84% | -14.80% |
Feb. 06 | Transcript : Boule Diagnostics AB, 2023 Earnings Call, Feb 06, 2024 | |
Feb. 06 | Transcript : Boule Diagnostics AB, 2023 Earnings Call, Feb 06, 2024 |
Sales 2023 | 571M 52.22M | Sales 2024 * | 580M 53M | Capitalization | 371M 33.94M |
---|---|---|---|---|---|
Net income 2023 | 25M 2.29M | Net income 2024 * | 28M 2.56M | EV / Sales 2023 | 0.87 x |
Net Debt 2023 | 60.2M 5.5M | Net Debt 2024 * | 77.93M 7.12M | EV / Sales 2024 * | 0.77 x |
P/E ratio 2023 |
17.5
x | P/E ratio 2024 * |
12.9
x | Employees | 200 |
Yield 2023 * |
2.04% | Yield 2024 * |
2.14% | Free-Float | 61.67% |
Latest transcript on Boule Diagnostics AB
1 day | -0.21% | ||
1 week | +0.84% | ||
Current month | -3.73% | ||
1 month | -4.78% | ||
3 months | -13.25% | ||
6 months | -1.34% | ||
Current year | -14.80% |
Managers | Title | Age | Since |
---|---|---|---|
Holger Lembrér
DFI | Director of Finance/CFO | - | Dec. 31 |
Sales & Marketing | - | 21-09-30 | |
Aishat Bislieva
HRO | Human Resources Officer | - | 22-09-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 63 | 15-12-31 | |
Chairman | 72 | 20-12-31 | |
Director/Board Member | 57 | 13-12-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-17 | 9.56 | -0.21% | 1,013 |
24-04-16 | 9.58 | +1.48% | 20,871 |
24-04-15 | 9.44 | -0.42% | 4,404 |
24-04-12 | 9.48 | -0.84% | 6,092 |
24-04-11 | 9.56 | +0.84% | 8,362 |
Delayed Quote Nasdaq Stockholm, April 17, 2024 at 07:15 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-14.80% | 34M | |
+3.10% | 212B | |
+3.48% | 178B | |
+10.91% | 134B | |
+17.56% | 100B | |
-0.99% | 62.45B | |
+14.41% | 54.2B | |
-6.21% | 44.74B | |
-3.22% | 40.09B | |
+10.18% | 39.19B |
- Stock Market
- Equities
- BOUL Stock